title: Any evident MRI T2-lesion activity should guide change of therapy in multiple sclerosis--yes.
authors.forename: Gavin
authors.initials: G
authors.lastname: Giovannoni
mesh_terms: D015415:Biomarkers; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology*; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000175:diagnosis* / Q000188:drug therapy*; D017063:Outcome Assessment, Health Care / Q000592:standards*; D066127:White Matter / Q000473:pathology*
chemical_list: D015415:Biomarkers; D007155:Immunologic Factors
keywords: MRI; Multiple sclerosis; T2-lesions; outcome measure